Explore the most common pharmaceutical deviations in Bangladesh: Learn expert Root Cause Analysis (RCA) techniques and CAPA strategies for DGDA & GMP compliance The pharmaceutical landscape in Bangladesh has evolved from a local manufacturing hub to a sophisticated global exporter. Read More …
Month: May 2026
Avoid FDA 483 in 2026: Common Pharmaceutical Compliance Mistakes & Expert Solutions
In 2026, pharmaceutical compliance is no longer limited to traditional GMP documentation. Regulators globally are focusing on data integrity, AI governance, digital quality systems, contamination control, laboratory reliability, batch release justification, and supply-chain oversight. The core message is clear: a Read More …